Differential proteome analysis of conditioned media to detect Smad4 regulated secreted biomarkers in colon cancer
- 28 June 2005
- journal article
- research article
- Published by Wiley in Proteomics
- Vol. 5 (10), 2587-2601
- https://doi.org/10.1002/pmic.200401188
Abstract
Smad4 is a tumor suppressor gene primarily involved in carcinogenesis of the pancreas and colon. The functional inactivation of Smad4 is a late step genetically. In pancreatic carcinogenesis, loss of Smad4 marks the transition to invasive growth. In colorectal cancers, the frequency of Smad4 inactivation is markedly increased in metastatic cancers. We have established cell biological models, re‐expressing Smad4 in deficient human cancer cells, in which we could show that Smad4 is adequate to suppress tumor growth through suppression of angiogenic and invasive properties. Thus, pairs of Smad4‐re‐expressing and Smad4‐deficient cells are prone to model the progression from premalignant stages to carcinomas in the carcinogenic process and may provide access to Smad4 targets of high clinical relevance. We present here a “differential secretome analysis”, comparing all the proteins released in vitro from the Smad4‐deficient and Smad4‐re‐expressing SW480 human colon carcinoma cells. The differential secretome catalog comprises more than 25 proteins including proteases and protease inhibitors, as well as established tumor biomarkers. In conclusion, this approach proved to be a sensitive tool to specifically detect Smad4 targets relevant for tumor‐stroma interactions. It is also able to reflect complex alterations of cellular physiology. Moreover, the results support our hypothesis that human tumor markers detectable in serum may be identified through differential secretome analyses.Keywords
This publication has 63 references indexed in Scilit:
- New insights into TGF-β–Smad signallingTrends in Biochemical Sciences, 2004
- Smad-dependent and Smad-independent pathways in TGF-β family signallingNature, 2003
- DPC4/SMAD4 mediated tumor suppression of colon carcinoma cells is associated with reduced urokinase expressionOncogene, 1999
- Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasisOncogene, 1999
- Decreased branching, increased fucosylation and changed sialylation of alpha-1-proteinase inhibitor in breast and ovarian cancerClinica Chimica Acta; International Journal of Clinical Chemistry, 1995
- Properties of α1-antitrypsin secreted by human adenocarcinoma cell linesFEBS Letters, 1993
- Molecular Cloning and Expression of the Transformation Sensitive Epithelial Marker StratifinJournal of Molecular Biology, 1993
- The levels of alpha1-antitrypsin and alpha1-antichymotrypsin in the sera of patients with gastrointestinal cancers during diagnosisCancer, 1988
- Improved silver staining procedure for fast staining in PhastSystem Development Unit. I. Staining of sodium dodecyl sulfate gelsElectrophoresis, 1988
- α1-antitrypsin microheterogeneityBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1982